Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-07-024509
Filing Date
2007-04-19
Accepted
2007-04-19 16:44:54
Documents
1
Period of Report
2007-04-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7283
  Complete submission text file 0001209191-07-024509.txt   9218
Mailing Address 20425 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876
Business Address 20425 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876 301 944 6600
SHALLCROSS STEVEN A (Reporting) CIK: 0001263501 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51863 | Film No.: 07776481

Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 300 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 300 ROCKVILLE MD 20850 240-599-4500
Vanda Pharmaceuticals Inc. (Issuer) CIK: 0001347178 (see all company filings)

EIN.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations